[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:ependymoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":141,"states":150},"Ependymoma",21,17,[8,16,23,29,35,42,48,54,60,66,72,78,84,91,97,103,109,115,122,128,134],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03750513","LET Optimized IMPT in Treating Pediatric Patients With Ependymoma",[12],"Phase 1","RECRUITING","2026-08-26T02:17:19.710918Z","2026-05-05T02:43:27.999286Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT01356290","Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors",[20],"Phase 2","2026-08-26T02:18:41.390601Z","2026-05-05T02:43:29.166226Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05106296","Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer",[12],"2026-08-26T02:19:06.150683Z","2026-05-05T02:43:27.323359Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT03911388","HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors",[12],"2026-08-26T02:16:16.169331Z","2026-07-30T01:46:14.458417Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT06639607","PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma\u002FHigh-grade Glioma and Recurrent Diffuse Midline Glioma\u002FHigh-grade Glioma, Medulloblastoma, and Ependymoma",[39],"Phase 1\u002FPhase 2","2026-08-03T00:58:26.564367Z","2026-07-05T05:32:16.689130Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06193759","Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)",[12],"2026-08-26T02:18:25.327036Z","2026-06-17T21:13:38.320470Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT04374305","Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)",[20],"2026-08-26T02:18:34.622081Z","2026-05-13T02:55:06.248563Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT04732065","ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors",[12],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:29.325044Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT04541082","Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms",[12],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.163334Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT04185038","Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma\u002FDiffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors",[12],"2026-08-26T02:18:51.833592Z","2026-05-05T02:43:28.903254Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06161519","PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications",[39],"2026-08-26T02:16:39.977107Z","2026-05-05T02:43:28.398018Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05857969","Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling",[12],"2026-08-26T02:18:00.873391Z","2026-05-05T02:43:28.220097Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":89,"content_modified":90},"NCT07017816","A Phase 0\u002F1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.",[88],"Early Phase 1","2026-08-26T02:17:32.059863Z","2026-05-05T02:43:27.319544Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT04099797","C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)",[12],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:27.089113Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT07698899","A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)",[12],"2026-08-26T02:18:49.989941Z","2026-07-19T19:36:05.081790Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT00598351","Natural History Study of Patients With Neurofibromatosis Type 2",[],"2026-08-26T02:18:07.037408Z","2026-05-13T02:55:06.039407Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT05057702","Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma",[],"2026-08-26T02:17:57.997171Z","2026-05-05T02:43:27.628617Z",{"nct_id":116,"title":117,"phases":118,"status":119,"updated_at":120,"content_modified":121},"NCT07390539","B7-H3.CD28Z.CART in CNS Neoplasms",[12],"NOT_YET_RECRUITING","2026-08-26T02:15:10.362237Z","2026-05-05T02:43:29.514138Z",{"nct_id":123,"title":124,"phases":125,"status":119,"updated_at":126,"content_modified":127},"NCT07609472","FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma",[20],"2026-08-26T02:16:42.787115Z","2026-07-05T05:32:16.642103Z",{"nct_id":129,"title":130,"phases":131,"status":119,"updated_at":132,"content_modified":133},"NCT07628647","Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being",[],"2026-08-26T02:17:39.048487Z","2026-06-06T00:48:49.527200Z",{"nct_id":135,"title":136,"phases":137,"status":138,"updated_at":139,"content_modified":140},"NCT05835687","Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:23:28.660374Z","2026-05-05T02:43:27.753658Z",[142,146],{"biomarker":143,"count":144,"slug":145},"Histone H3 Lysine 28",4,"histone-h3-lysine-28",{"biomarker":147,"count":148,"slug":149},"CD276 wt Allele",3,"cd276-wt-allele",[151,155,158,161,164,167,170,173,176],{"state":152,"count":153,"slug":154},"Texas",6,"texas",{"state":156,"count":144,"slug":157},"District of Columbia","district-of-columbia",{"state":159,"count":144,"slug":160},"Maryland","maryland",{"state":162,"count":144,"slug":163},"Massachusetts","massachusetts",{"state":165,"count":148,"slug":166},"California","california",{"state":168,"count":148,"slug":169},"Florida","florida",{"state":171,"count":148,"slug":172},"Missouri","missouri",{"state":174,"count":148,"slug":175},"New York","new-york",{"state":177,"count":148,"slug":178},"Pennsylvania","pennsylvania"]